Brought to you by 
Merck KGAA to buy Serono for CHF16.6bn
Sep 2006
Executive Summary
Merck KGAA has agreed to acquire Geneva-based biotech Serono SA in a deal valued at CHF16.6bn ($12.9bn). Merck will initially buy out majority shareholders the Bertarelli family, which accounts for a 64.5% stake in Serono; the company plans to continue with a public tender offer in 2007 to acquire the remaining shares.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merck KGAA to buy Serono for CHF16.6bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice